Growth Metrics

BridgeBio Pharma (BBIO) EPS (Basic) (2018 - 2026)

BridgeBio Pharma recorded quarterly EPS (Basic) of -$0.84 in Q1 2026, up 15.15% quarter-over-quarter from -$0.99 in Q4 2025, and up 4.55% year-over-year from -$0.8 in Q1 2025.

BridgeBio Pharma's EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.84 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 4.55% year-over-year to -$0.84; the TTM figure through Mar 2026 stood at -$3.73 (down 5.07% YoY), while the FY2025 annual figure was -$3.78, down 31.25% from the prior year.
  • EPS (Basic) came in at -$0.84 for Q1 2026 at BridgeBio Pharma, up from -$0.99 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.07 in Q2 2022 to a low of -$1.42 in Q4 2024.
  • A 5-year average of -$0.86 and a median of -$0.93 in 2022 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) jumped 89.39% in 2022 and plunged 1300.0% in 2023, its largest moves.
  • BridgeBio Pharma's EPS (Basic) stood at -$0.92 in 2022, then retreated by 4.35% to -$0.96 in 2023, then sank by 47.92% to -$1.42 in 2024, then jumped by 30.28% to -$0.99 in 2025, then increased by 15.15% to -$0.84 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods registered -$0.84, -$0.99, and -$0.95 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 3.06
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 0.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 4.06
7 Evaxion A 64.16 Bn 64.14 Bn - 0.00
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.55
10 BridgeBio Pharma 12.91 Bn 11.98 Bn 184.58 Mn -0.84

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.84
Dec 31, 2025 -0.99
Sep 30, 2025 -0.95
Jun 30, 2025 -0.95
Mar 31, 2025 -0.88
Dec 31, 2024 -1.42
Sep 30, 2024 -0.86
Jun 30, 2024 -0.39
Mar 31, 2024 -0.20
Dec 31, 2023 -0.96
Sep 30, 2023 -1.08
Jun 30, 2023 -0.98
Mar 31, 2023 -0.92
Dec 31, 2022 -0.92
Sep 30, 2022 -0.93
Jun 30, 2022 -0.07
Mar 31, 2022 -1.35
Dec 31, 2021 -1.02
Sep 30, 2021 -1.06
Jun 30, 2021 -0.66
Mar 31, 2021 -1.18
Dec 31, 2020 -1.01
Sep 30, 2020 -0.98
Jun 30, 2020 -1.03
Mar 31, 2020 -0.78
Dec 31, 2019 -0.62
Sep 30, 2019 -0.51
Jun 30, 2019 -0.71
Mar 31, 2019 -0.66
Dec 31, 2018 -0.52
Sep 30, 2018 -0.52
Jun 30, 2018 -1.71